海正药业 (600267.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(海正药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 2,726,615,253.7010,373,071,956.928,700,895,404.716,060,103,056.033,063,534,009.2212,036,690,081.668,743,908,274.305,736,689,223.532,977,204,828.98
 营业利润(元) 272,881,031.2089,442,971.17629,069,077.94550,256,415.27295,762,745.82682,478,422.12490,843,786.59410,422,340.19181,607,982.50
 利润总额(元) 270,589,142.98-82,866,731.58580,799,298.28503,502,808.33295,646,621.49683,422,685.30487,612,975.20407,961,490.93183,816,282.58
 净利润(元) 246,349,992.85-97,014,961.51472,914,417.84431,107,180.61241,532,224.51491,419,477.85338,165,183.70319,361,916.60135,971,298.82
 归属于母公司股东的净利润(元) 248,531,288.09-93,171,306.60457,097,549.01419,411,807.41232,298,844.11489,045,084.28331,078,759.05319,001,147.09135,128,838.42
盈利能力:
 销售毛利率(%) 36.1540.3441.3041.5640.2441.8641.0240.1739.31
 销售净利率(%) 9.04-0.945.447.117.884.083.875.574.57
 净资产收益率(%) 3.04-1.155.605.212.95----
 总资产报酬率ROA(%) 1.700.603.983.261.84----
 投入资本回报率ROIC(%) 1.77-0.653.102.821.553.272.242.090.88
营运能力:
 存货周转率(次) 0.933.202.912.080.99----
 应收账款周转率(次) 1.234.743.582.511.32----
 总资产周转率(次) 0.150.570.470.330.16----
偿债能力:
 资产负债率(%) 52.4452.6051.2151.5054.4655.6456.8860.1161.50
 股东权益比率(%) 46.1546.0047.3147.0744.1543.0241.7439.6838.28
 已获利息倍数(倍) 8.130.574.905.916.293.603.493.913.47
 流动比率 0.880.971.000.960.960.900.850.760.76
 速动比率 0.600.630.690.660.650.590.590.520.52
发展能力:
 营业收入增长率(%) -11.00-13.82-0.495.642.90-0.82-3.99-4.46-2.96
 营业利润增长率(%) -7.74-86.8928.1634.0762.86-2.51-21.976.10-22.87
 税后利润增长率(%) 6.99-119.0638.0331.4771.910.44-33.7113.887.48
 净资产增长率(%) -3.280.2810.9515.5911.6210.625.224.656.49
 总资产增长率(%) -7.47-6.20-2.11-2.55-3.23-3.08-7.12-5.40-2.26

前瞻产业研究院